13F HOLDINGS REPORT
Integral Health Asset Management, LLC
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001172661-24-002421
Total Value
$1.08B
Positions
80
Other Managers
0
Confidential Omitted
No
Holdings (80)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | TENET HEALTHCARE CORP | THC | 425,000 | $44.7M | 4.15% |
| 2 | BOSTON SCIENTIFIC CORP | BSX | 600,000 | $41.1M | 3.81% |
| 3 | VIKING THERAPEUTICS INC | VKTX | 450,000 | $36.9M | 3.43% |
| 4 | INSMED INC | INSM | 1,300,000 | $35.3M | 3.27% |
| 5 | CYTOKINETICS INC | CYTK | 450,000 | $31.5M | 2.93% |
| 6 | MERCK & CO INC | MRK | 235,000 | $31.0M | 2.88% |
| 7 | ENCOMPASS HEALTH CORP | EHC | 350,000 | $28.9M | 2.68% |
| 8 | WALGREENS BOOTS ALLIANCE INC | 931427108 | 1,300,000 | $28.2M | 2.62% |
| 9 | ELEVANCE HEALTH INC | ELV | 50,000 | $25.9M | 2.41% |
| 10 | VIKING THERAPEUTICS INC | VKTX | 300,000 | $24.6M | 2.28% |
| 11 | ABBVIE INC | ABBV | 135,000 | $24.6M | 2.28% |
| 12 | UNIVERSAL HLTH SVCS INC | 913903100 | 125,000 | $22.8M | 2.12% |
| 13 | NOVARTIS AG | NVSEF | 225,000 | $21.8M | 2.02% |
| 14 | TARSUS PHARMACEUTICALS INC | TARS | 590,000 | $21.4M | 1.99% |
| 15 | LONGBOARD PHARMACEUTICALS IN | 54300N103 | 975,000 | $21.1M | 1.95% |
| 16 | HUMANA INC | HUM | 60,000 | $20.8M | 1.93% |
| 17 | NEUROCRINE BIOSCIENCES INC | NBIX | 150,000 | $20.7M | 1.92% |
| 18 | BRUKER CORP | BRKRP | 220,000 | $20.7M | 1.92% |
| 19 | INTUITIVE SURGICAL INC | ISRG | 50,000 | $20.0M | 1.85% |
| 20 | BLUEPRINT MEDICINES CORP | 09627Y109 | 210,000 | $19.9M | 1.85% |
| 21 | ARCELLX INC | ACLX | 255,000 | $17.7M | 1.65% |
| 22 | CHARLES RIV LABS INTL INC | 159864107 | 65,000 | $17.6M | 1.63% |
| 23 | REGENERON PHARMACEUTICALS | REGN | 17,000 | $16.4M | 1.52% |
| 24 | REGENXBIO INC | RGNX | 760,000 | $16.0M | 1.49% |
| 25 | PENUMBRA INC | PEN | 70,000 | $15.6M | 1.45% |
| 26 | VERA THERAPEUTICS INC | VERA | 360,000 | $15.5M | 1.44% |
| 27 | CRINETICS PHARMACEUTICALS IN | CRNX | 325,000 | $15.2M | 1.41% |
| 28 | ICON PLC | ICLR | 45,000 | $15.1M | 1.40% |
| 29 | CRISPR THERAPEUTICS AG | CRSP | 220,000 | $15.0M | 1.39% |
| 30 | THE CIGNA GROUP | 125523100 | 40,000 | $14.5M | 1.35% |
| 31 | KRYSTAL BIOTECH INC | KRYS | 80,000 | $14.2M | 1.32% |
| 32 | DEXCOM INC | DXCM | 100,000 | $13.9M | 1.29% |
| 33 | INSMED INC | INSM | 500,000 | $13.6M | 1.26% |
| 34 | REVOLUTION MEDICINES INC | RVMDW | 420,000 | $13.5M | 1.26% |
| 35 | SHOCKWAVE MED INC | 82489T104 | 40,000 | $13.0M | 1.21% |
| 36 | AVANTOR INC | AVTR | 500,000 | $12.8M | 1.19% |
| 37 | CENCORA INC | COR | 50,000 | $12.1M | 1.13% |
| 38 | TENAYA THERAPEUTICS INC | TNYA | 2,250,000 | $11.8M | 1.09% |
| 39 | COOPER COS INC | 216648501 | 110,000 | $11.2M | 1.04% |
| 40 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 220,000 | $11.1M | 1.03% |
| 41 | EXACT SCIENCES CORP | 30063P105 | 150,000 | $10.4M | 0.96% |
| 42 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 200,000 | $10.0M | 0.93% |
| 43 | SANA BIOTECHNOLOGY INC | SANA | 980,000 | $9.8M | 0.91% |
| 44 | INARI MED INC | 45332Y109 | 200,000 | $9.6M | 0.89% |
| 45 | ELI LILLY & CO | LLY | 12,000 | $9.3M | 0.87% |
| 46 | REPLIGEN CORP | RGEN | 50,000 | $9.2M | 0.85% |
| 47 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 230,000 | $9.1M | 0.85% |
| 48 | ELANCO ANIMAL HEALTH INC | ELAN | 550,000 | $9.0M | 0.83% |
| 49 | APELLIS PHARMACEUTICALS INC | APLS | 150,000 | $8.8M | 0.82% |
| 50 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 125,000 | $8.7M | 0.80% |
| 51 | EVOLENT HEALTH INC | EVH | 250,000 | $8.2M | 0.76% |
| 52 | TANDEM DIABETES CARE INC | TNDM | 225,000 | $8.0M | 0.74% |
| 53 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 250,000 | $8.0M | 0.74% |
| 54 | ALNYLAM PHARMACEUTICALS INC | ALNY | 50,000 | $7.5M | 0.69% |
| 55 | OSCAR HEALTH INC | OSCR | 500,000 | $7.4M | 0.69% |
| 56 | MERUS N V | N5749R100 | 165,000 | $7.4M | 0.69% |
| 57 | MACROGENICS INC | MGNX | 500,000 | $7.4M | 0.68% |
| 58 | CABALETTA BIO INC | CABA | 425,000 | $7.3M | 0.67% |
| 59 | INSPIRE MED SYS INC | 457730109 | 33,000 | $7.1M | 0.66% |
| 60 | ALKERMES PLC | ALKS | 250,000 | $6.8M | 0.63% |
| 61 | ROIVANT SCIENCES LTD | ROIV | 600,000 | $6.3M | 0.59% |
| 62 | BEIGENE LTD | BEIGF | 40,000 | $6.3M | 0.58% |
| 63 | RELAY THERAPEUTICS INC | RLAY | 725,000 | $6.0M | 0.56% |
| 64 | SCHOLAR ROCK HLDG CORP | SRRK | 325,000 | $5.8M | 0.54% |
| 65 | REVVITY INC | RVTY | 50,000 | $5.3M | 0.49% |
| 66 | ALIGN TECHNOLOGY INC | ALGN | 15,000 | $4.9M | 0.46% |
| 67 | NATERA INC | NTRA | 50,000 | $4.6M | 0.42% |
| 68 | LABORATORY CORP AMER HLDGS | 50540R409 | 20,000 | $4.4M | 0.41% |
| 69 | AGILENT TECHNOLOGIES INC | A | 30,000 | $4.4M | 0.41% |
| 70 | SPYRE THERAPEUTICS INC | SYRE | 100,000 | $3.8M | 0.35% |
| 71 | SAGE THERAPEUTICS INC | 78667J108 | 200,000 | $3.7M | 0.35% |
| 72 | 89BIO INC | 282559103 | 300,000 | $3.5M | 0.32% |
| 73 | EDITAS MEDICINE INC | EDIT | 450,000 | $3.3M | 0.31% |
| 74 | AUTOLUS THERAPEUTICS PLC | AUTL | 500,000 | $3.2M | 0.30% |
| 75 | MEREO BIOPHARMA GROUP PLC | MREO | 950,000 | $3.1M | 0.29% |
| 76 | GUARDANT HEALTH INC | GH | 150,000 | $3.1M | 0.29% |
| 77 | APOGEE THERAPEUTICS INC | APGE | 40,000 | $2.7M | 0.25% |
| 78 | KEROS THERAPEUTICS INC | KROS | 40,000 | $2.6M | 0.25% |
| 79 | AXSOME THERAPEUTICS INC | AXSM | 30,000 | $2.4M | 0.22% |
| 80 | FATE THERAPEUTICS INC | FATE | 200,000 | $1.5M | 0.14% |